Bulletin
Investor Alert

Nov. 11, 2019, 6:52 a.m. EST

Neptune Wellness reports wider loss, enters CBD co-development deal with International Flavors & Fragrances

Neptune Wellness Solutions Inc. (NAS:NEPT) (TSE:CA:NEPT) reported Monday a fiscal second-quarter net loss that widened to C$20.78 million ($15.7 million), from a loss of $3.05 million a year ago. The Canada-based cannabis extraction company said the increased loss is due primarily to an increase in stock-based compensation expense, depreciation and amortization and increased expenses on contingent consideration. Revenue fell to C$6.51 million ($4.9 million) from C$7.07 million. Cannabis revenue reached C$1.22 million after having no cannabis revenue last year, while nutraceutical revenue fell to C$5.15 million from C$7.07 million, due to the timing of orders of the nutrition business. Separately, Neptune announced an agreement with International Flavors & Fragrances Inc. (NYS:IFF) to develop hemp-derived cannabidiol (CBD) products for the mass retail and health and wellness markets. Under terms of the agreement, Neptune will issue 2 million warrants to IFF, which each warrant allowing the purchase of one Neptune common share at an exercise price of $12.00 per share. The co-development agreement will include a variety of topical aromatherapy products. Neptune's U.S.-listed stock, which was still inactive in premarket trading, has tumbled 27% over the past three months, while the ETFMG Alternative Harvest ETF (PSE:MJ) has plunged 31% and the S&P 500 (S&P:SPX) has gained 6.0%.

Link to MarketWatch's Slice.